中文
中文
关于天科雅
研究与发展
产品及临床
新闻与媒体
招贤纳士
为了病患而驱动的创新
Patient-first cell therapy innovation

首页研究与发展科学论文
科学论文
科学论文
SCIENTIFIC PUBLICATION
  • 03.232022
    2018
    Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 9(1):5361. (*: Corresponding authors, PMCID: PMC6299138)Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y.,
    了解更多
  • 03.232022
    Dr. Qi-Jing Li’s Publication
    Dr. Li has published more than 100 papers on Cell, Cancer Cell, Nature, Nature Immunology, Immunity, EMBO, and Nature Communication, etc. His publications have been cited for more than 9000 times. Below are some selected papers with significant impacts in the scientific field.
    了解更多
  • 03.232022
    Dr. Pin Wang’s Publication
    Dr. Wang has published more than 80 papers on Nature Biotechnology, Cell Stem Cell, PNAS, Nature Communication, ACS Nano, and Molecular Therapy, etc. He has also filed more than 10 patents as lead inventor or co-inventor. Below are some selected papers and patents with significant impacts in the scientific field.
    了解更多
12
查看更多

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

 粤ICP备20056630号 Powered by vancheer
联系我们
关于天科雅
研究与发展
产品及临床
新闻与媒体
招贤纳士

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

 粤ICP备20056630号 Powered by vancheer